|
| 36287107 | HDAC1 regulates the chromatin landscape to control transcriptional dependencies in chronic lymphocytic leukemia. | Blood Adv | 2023 |
| 38053181 | Association between viral infections and glioma risk: a two-sample bidirectional Mendelian randomization analysis. | BMC Med | 2023 |
| 37456028 | Triethylammonium salt of a synthesized dicoumarol: Structural insight and human anti-glioblastoma activities. | Heliyon | 2023 |
| 37188783 | Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial. | Nat Med | 2023 |
| 37114244 | Characterization of recurrence patterns and outcomes of medulloblastoma in adults: The University of Texas MD Anderson Cancer Center experience. | Neurooncol Adv | 2023 |
| 36968288 | Tumor microenvironment in glioblastoma: Current and emerging concepts. | Neurooncol Adv | 2023 |
| 36968138 | Multicenter Phase II Trial of the PARP Inhibitor Olaparib in Recurrent <i>IDH1-</i> and <i>IDH2</i>-mutant Glioma. | Cancer Res Commun | 2023 |
| 37227811 | Characterization of industry relationships in oncology. | Cancer | 2023 |
| 36723868 | An expedited strategy for accurate and timely integrated molecular diagnosis of gliomas. | Neuro Oncol | 2023 |
| 36831427 | A Case Study of Chimeric Antigen Receptor T Cell Function: Donor Therapeutic Differences in Activity and Modulation with Verteporfin. | Cancers (Basel) | 2023 |
| 36634606 | NCCN Guidelines® Insights: Central Nervous System Cancers, Version 2.2022. | J Natl Compr Canc Netw | 2023 |
| 34260721 | Inhibition of nicotinamide phosphoribosyltransferase (NAMPT), the rate-limiting enzyme of the nicotinamide adenine dinucleotide (NAD) salvage pathway, to target glioma heterogeneity through mitochondrial oxidative stress. | Neuro Oncol | 2022 |
| 35344029 | Infigratinib in Patients with Recurrent Gliomas and FGFR Alterations: A Multicenter Phase II Study. | Clin Cancer Res | 2022 |
| 35367525 | Phase I study of trametinib in combination with whole brain radiation therapy for brain metastases. | Radiother Oncol | 2022 |
| 36128585 | Patterns of failure after radiation therapy in primary spinal high-grade gliomas: A single institutional analysis. | Neurooncol Adv | 2022 |
| 35140124 | Disruption of DNA Repair and Survival Pathways through Heat Shock Protein Inhibition by Onalespib to Sensitize Malignant Gliomas to Chemoradiation Therapy. | Clin Cancer Res | 2022 |
| 34561270 | Designing Clinical Trials for Combination Immunotherapy: A Framework for Glioblastoma. | Clin Cancer Res | 2022 |
| 33264399 | Demystifying demethylator sensitivity in gliomas: role for TERT and DNMT1. | Neuro Oncol | 2021 |
| 33822177 | Report of National Brain Tumor Society roundtable workshop on innovating brain tumor clinical trials: building on lessons learned from COVID-19 experience. | Neuro Oncol | 2021 |
| 35088051 | Prospective biomarker study in newly diagnosed glioblastoma: Cyto-C clinical trial. | Neurooncol Adv | 2021 |
| 34613491 | Targeted Therapy for BRAF Mutant Brain Tumors. | Curr Treat Options Oncol | 2021 |
| 34377987 | Clinical characterization of adult medulloblastoma and the effect of first-line therapies on outcome; The MD Anderson Cancer Center experience. | Neurooncol Adv | 2021 |
| 34667950 | Prognostic implications of epidermal and platelet-derived growth factor receptor alterations in 2 cohorts of IDH<i>wt</i> glioblastoma. | Neurooncol Adv | 2021 |
| 34693288 | Results of a phase I trial to assess the safety of macitentan in combination with temozolomide for the treatment of recurrent glioblastoma. | Neurooncol Adv | 2021 |
| 34651117 | Assessment of Leptomeningeal Carcinomatosis Diagnosis, Management and Outcomes in Patients with Solid Tumors Over a Decade of Experience. | Eur J Breast Health | 2021 |
| 34215688 | Systematic review of combinations of targeted or immunotherapy in advanced solid tumors. | J Immunother Cancer | 2021 |
| 34258581 | Erratum to: Characterizing Benefit from Temozolomide in MGMT Promoter Unmethylated and Methylated Glioblastoma: A Systematic Review and Meta-analysis. | Neurooncol Adv | 2021 |
| 34026655 | Tumor Treating Fields for Glioblastoma Therapy During the COVID-19 Pandemic. | Front Oncol | 2021 |
| 33059358 | Management of gliomas in patients with Lynch syndrome. | Neuro Oncol | 2021 |
| 32479630 | SNO 25th anniversary history series: Investing in the membership of the Society for Neuro-Oncology. | Neuro Oncol | 2020 |
| 33880446 | An evaluation of <i>MGMT</i> promoter methylation within the methylation subclasses of glioblastoma. | Neurooncol Adv | 2020 |
| 33664972 | The role of VEGF receptor inhibitors in preventing cerebral radiation necrosis: a retrospective cohort study. | Neurooncol Pract | 2020 |
| 33373402 | Phase I trial of intracerebral convection-enhanced delivery of carboplatin for treatment of recurrent high-grade gliomas. | PLoS One | 2020 |
| 33152694 | Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology. | J Natl Compr Canc Netw | 2020 |
| 33150334 | Characterizing benefit from temozolomide in MGMT promoter unmethylated and methylated glioblastoma: a systematic review and meta-analysis. | Neurooncol Adv | 2020 |
| 32889892 | False-positive 1p/19q Testing Results in Gliomas: Clinical and Research Consequences. | Am J Clin Oncol | 2020 |
| 32804242 | SNO 25th anniversary history series: The SNO Annual Meeting - A nexus for science, collaboration and community. | Neuro Oncol | 2020 |
| 32602020 | Early imaging marker of progressing glioblastoma: a window of opportunity. | J Neurooncol | 2020 |
| 32995879 | SNO 25th anniversary history series: Providing a global platform for communication and exchange in neuro-oncology. | Neuro Oncol | 2020 |
| 32991721 | SNO 25th anniversary history series: Ancillary and satellite meetings of the Society for Neuro-Oncology. | Neuro Oncol | 2020 |
| 32415306 | Celebrating SNO's official journal, Neuro-Oncology. | Neuro Oncol | 2020 |
| 32411090 | TTF-1 Positive Primary Small Cell Carcinoma of the Breast: A Case Report and Review of the Literature. | Front Endocrinol (Lausanne) | 2020 |
| 32518956 | SNO 25th anniversary history series: Spotlight on Neuro-Oncology Practice and Neuro-Oncology Advances. | Neuro Oncol | 2020 |
| 32166308 | A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastoma. | Neuro Oncol | 2020 |
| 32559414 | Targeting DGAT1 Ameliorates Glioblastoma by Increasing Fat Catabolism and Oxidative Stress. | Cell Metab | 2020 |
| 30359477 | Phase 1 lead-in to a phase 2 factorial study of temozolomide plus memantine, mefloquine, and metformin as postradiation adjuvant therapy for newly diagnosed glioblastoma. | Cancer | 2019 |
| 31448156 | Stroke-Like Migraine Attacks after Radiation Therapy Syndrome: Clinical and Imaging Characteristics. | J Clin Imaging Sci | 2019 |
| 31128312 | Spinal Cord Toxicity from Intrathecal Chemotherapy: A Case with Clinicopathologic Correlation. | World Neurosurg | 2019 |
| 30773117 | HSP90 inhibition depletes DNA repair proteins to sensitize acute myelogenous leukemia to nucleoside analog chemotherapeutics. | Leuk Lymphoma | 2019 |
| 31106606 | Changing paradigms for targeted therapies against diffuse infiltrative gliomas: tackling a moving target. | Expert Rev Neurother | 2019 |